DBCO-Maleimide (DBCO-MAL) is a heterobifunctional, non-cleavable linker used in constructing antibody-drug conjugates (ADCs). It enables stable, site-specific conjugation via copper-free click chemistry and maleimide-thiol coupling, facilitating ADC development for both in vitro and in vivo cancer research applications.